JP TSE 4591 Pharmaceutical

RIBOMIC Inc.

株式会社リボミック

Revenue

¥3.0M

≈ $19K

Net income

−¥1.1B

≈ −$7.3M

Income taxes paid

¥2.4M

≈ $15K

Total assets

¥3.0B

≈ $18.9M

Equity ratio

95.5%

Ranked #2,980 among listed Japanese companies by corporate taxes paid.

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥3.0M	−¥1.1B	¥1.2M	¥2.4M	¥3.0B	¥2.8B	95.5%	EDINET
Mar 2025	¥2.1M	−¥1.0B	¥1.2M	¥1.7M	¥3.2B	¥3.0B	95.5%	EDINET
Mar 2024	—	−¥1.0B	—	—	¥3.5B	¥3.4B	95.6%	EDINET
Mar 2023	¥66.0M	−¥1.7B	—	—	¥4.6B	¥4.4B	95.7%	EDINET
Mar 2022	¥80.9M	−¥1.7B	—	—	¥5.0B	¥4.7B	94.7%	EDINET

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.